January 10, 2010
1 min read
Save

Blue light-filtering IOL may inhibit onset, progression of AMD

Invest Ophthalmol Vis Sci. 2009;50(10):4777-4785.

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Implantation of a blue light-filtering IOL may prevent or delay the development of age-related macular degeneration, according to a study.

Previous studies have shown an association between cataract surgery and exposure of the retina to blue light, a factor in AMD development. Macular pigment may protect the retina against AMD resulting from blue light exposure, the study authors said.

The prospective, randomized study included 42 patients; 21 patients were implanted with an AcrySof Natural IOL (Alcon) and 21 patients received an AcrySof three-piece acrylic IOL (Alcon). The AcrySof Natural has blue light-filtering capability. Mean patient age was 74 years in the AcrySof Natural group and 71 years in the AcrySof group.

Investigators measured macular pigment optical density 1 week before surgery, 1 week after surgery, and 3, 6 and 12 months after surgery. Serum concentrations of the carotenoids lutein and zeaxanthin were assessed at each follow-up visit.

Study data showed that average macular pigment optical density across the retina was significantly increased at 3 months in the AcrySof Natural group; macular pigment optical density was stable in the AcrySof group. Results showed that implantation of a blue light-filtering IOL increased macular pigment optical density in the absence of raised lutein and zeaxanthin serum levels.

"However, further study is required in the form of controlled long-term trials to investigate whether implantation of a blue light-filtering IOL is effective in preventing or delaying development or progression of AMD," the authors said.

PERSPECTIVE

Blue blocking IOLs theoretically provide better photoprotection but worse photoreception than conventional UV-only blocking IOLs. Dr. Nolan reports the unexpected result that macular pigment density remains unchanged after cataract surgery with a UV-only blocking IOL but increases after cataract surgery with a blue blocking IOL. The significance of the variation in pigmentation remains unknown.

– Mark Packer, MD
Drs. Fine, Hoffman and Packer, Eugene, Ore.